The global swine influenza vaccines market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The live vaccines segment is expected to dominate the market with a share of over 60%. The live vaccines segment is expected to grow at a CAGR of 6.2% during the forecast period, from 2021 to 2030. The commodity pig segment accounted for over 50% share in 2018 and it is expected that this segment will continue its dominance throughout the forecast period, with an estimated growth rate of 6.3%.
- Increasing awareness about the disease and its prevention methods is also expected to drive growth in this market over the forecast period (2017-2022).
- The increasing number of outbreaks across various regions is also expected to fuel demand for swine influenza vaccines over the forecast period (2017-2022) For instance, in 2016, there were more than 1 million cases reported globally with more than 100 deaths reported in China alone due to H1N1 virus infection which was followed by an outbreak in India with more than 10 deaths reported due to H1N1 virus infection as well as an outbreak in Mexico with more than 50 deaths reported due to H3N2 virus infection among others such as Russia and Ukraine among others which are all contributing factors that will drive growth for this market over the forecast period (2017-2022).
Industry Growth Insights published a new data on “Swine Influenza Vaccines Market”. The research report is titled “Swine Influenza Vaccines Market research by Types (Live Vaccines, Killed Vaccines), By Applications (Commodity Pig, Breeding Pig), By Players/Companies Chengdu TECBOND, Green Cross Veterinary, Hipra, MSD Animal Health (Merck), Zoetis, CAHIC, Merial , Ceva, Ringpu Biology, DHN”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Swine Influenza Vaccines Market Research Report
By Type
Live Vaccines, Killed Vaccines
By Application
Commodity Pig, Breeding Pig
By Companies
Chengdu TECBOND, Green Cross Veterinary, Hipra, MSD Animal Health (Merck), Zoetis, CAHIC, Merial , Ceva, Ringpu Biology, DHN
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
249
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Swine Influenza Vaccines Market Report Segments:
The global Swine Influenza Vaccines market is segmented on the basis of:
Types
Live Vaccines, Killed Vaccines
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Commodity Pig, Breeding Pig
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Chengdu TECBOND
- Green Cross Veterinary
- Hipra
- MSD Animal Health (Merck)
- Zoetis
- CAHIC
- MerialÂ
- Ceva
- Ringpu Biology
- DHN
Highlights of The Swine Influenza Vaccines Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Live Vaccines
- Killed Vaccines
- By Application:
- Commodity Pig
- Breeding Pig
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Swine Influenza Vaccines Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Swine influenza vaccines are a type of vaccine that helps protect people from the swine flu. They work by helping to prevent people from getting sick with the swine flu.
Some of the key players operating in the swine influenza vaccines market are Chengdu TECBOND, Green Cross Veterinary, Hipra, MSD Animal Health (Merck), Zoetis, CAHIC, Merial‚Â , Ceva, Ringpu Biology, DHN.
The swine influenza vaccines market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Swine Influenza Vaccines Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Swine Influenza Vaccines Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Swine Influenza Vaccines Market - Supply Chain
4.5. Global Swine Influenza Vaccines Market Forecast
4.5.1. Swine Influenza Vaccines Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Swine Influenza Vaccines Market Size (000 Units) and Y-o-Y Growth
4.5.3. Swine Influenza Vaccines Market Absolute $ Opportunity
5. Global Swine Influenza Vaccines Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Swine Influenza Vaccines Market Size and Volume Forecast by Type
5.3.1. Live Vaccines
5.3.2. Killed Vaccines
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Swine Influenza Vaccines Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Swine Influenza Vaccines Market Size and Volume Forecast by Application
6.3.1. Commodity Pig
6.3.2. Breeding Pig
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Swine Influenza Vaccines Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Swine Influenza Vaccines Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Swine Influenza Vaccines Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Swine Influenza Vaccines Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Swine Influenza Vaccines Demand Share Forecast, 2019-2026
9. North America Swine Influenza Vaccines Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Swine Influenza Vaccines Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Swine Influenza Vaccines Market Size and Volume Forecast by Application
9.4.1. Commodity Pig
9.4.2. Breeding Pig
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Swine Influenza Vaccines Market Size and Volume Forecast by Type
9.7.1. Live Vaccines
9.7.2. Killed Vaccines
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Swine Influenza Vaccines Demand Share Forecast, 2019-2026
10. Latin America Swine Influenza Vaccines Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Swine Influenza Vaccines Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Swine Influenza Vaccines Market Size and Volume Forecast by Application
10.4.1. Commodity Pig
10.4.2. Breeding Pig
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Swine Influenza Vaccines Market Size and Volume Forecast by Type
10.7.1. Live Vaccines
10.7.2. Killed Vaccines
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Swine Influenza Vaccines Demand Share Forecast, 2019-2026
11. Europe Swine Influenza Vaccines Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Swine Influenza Vaccines Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Swine Influenza Vaccines Market Size and Volume Forecast by Application
11.4.1. Commodity Pig
11.4.2. Breeding Pig
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Swine Influenza Vaccines Market Size and Volume Forecast by Type
11.7.1. Live Vaccines
11.7.2. Killed Vaccines
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Swine Influenza Vaccines Demand Share, 2019-2026
12. Asia Pacific Swine Influenza Vaccines Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Swine Influenza Vaccines Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Swine Influenza Vaccines Market Size and Volume Forecast by Application
12.4.1. Commodity Pig
12.4.2. Breeding Pig
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Swine Influenza Vaccines Market Size and Volume Forecast by Type
12.7.1. Live Vaccines
12.7.2. Killed Vaccines
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Swine Influenza Vaccines Demand Share, 2019-2026
13. Middle East & Africa Swine Influenza Vaccines Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Swine Influenza Vaccines Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Swine Influenza Vaccines Market Size and Volume Forecast by Application
13.4.1. Commodity Pig
13.4.2. Breeding Pig
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Swine Influenza Vaccines Market Size and Volume Forecast by Type
13.7.1. Live Vaccines
13.7.2. Killed Vaccines
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Swine Influenza Vaccines Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Swine Influenza Vaccines Market: Market Share Analysis
14.2. Swine Influenza Vaccines Distributors and Customers
14.3. Swine Influenza Vaccines Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Chengdu TECBOND
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Green Cross Veterinary
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Hipra
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. MSD Animal Health (Merck)
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Zoetis
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. CAHIC
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Merial
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Ceva
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Ringpu Biology
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. DHN
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
